Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 16, 2022

SELL
$225.82 - $368.51 $957,025 - $1.56 Million
-4,238 Closed
0 $0
Q3 2021

Nov 10, 2021

BUY
$221.9 - $484.47 $57,250 - $124,993
258 Added 6.48%
4,238 $1.63 Million
Q2 2021

Sep 08, 2021

SELL
$129.91 - $234.98 $96,133 - $173,885
-740 Reduced 15.68%
3,980 $935,000
Q1 2021

Sep 08, 2021

SELL
$109.18 - $185.98 $149,904 - $255,350
-1,373 Reduced 22.53%
4,720 $618,000
Q4 2020

Sep 08, 2021

BUY
$65.74 - $169.86 $201,690 - $521,130
3,068 Added 101.42%
6,093 $637,000
Q3 2020

Sep 08, 2021

SELL
$54.34 - $94.85 $46,732 - $81,571
-860 Reduced 22.14%
3,025 $214,000
Q2 2020

Sep 08, 2021

BUY
$29.67 - $80.0 $115,267 - $310,800
3,885 New
3,885 $249,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $14.4B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track J Arnold Wealth Management CO Portfolio

Follow J Arnold Wealth Management CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of J Arnold Wealth Management CO, based on Form 13F filings with the SEC.

News

Stay updated on J Arnold Wealth Management CO with notifications on news.